| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Teva Pharmaceutical Industries Limited (TEVA) have been net sellers, shedding 441,824 shares worth roughly $17.0M on balance.
TEVA sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.12M | - | - | |
| CEO | 1.18M | - | - | |
| Dir | 448.0K | - | - | |
| Dir | 130.1K | - | - | |
| Dir | 127.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 62,250 | $16.06 | $999,424.86 | -100% | +10.0% | +109.8% | |
| Feb 28, 2025 | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | Sale+OE | 55,750 | $16.21 | $903,462.20 | -27.4% | +6.5% | +105.7% | |
| Feb 18, 2025 | Francis Richard D | President And CEO | Sale+OE | 75,506 | $16.95 | $1,279,660.59 | -26.5% | +2.7% | +105.9% | |
| Feb 12, 2025 | Sabag Mark | See "remarks" | Sell | 177,626 | $16.25 | $2,886,564.60 | -46.4% | +7.0% | +107.6% | |
| Dec 20, 2024 | Mignone Roberto | Director | Sell | 286,000 | $22.01 | $6,294,030.60 | -29.2% | -26.5% | +37.4% | |
| Nov 20, 2024 | Fox Christine | EVP, Head Of U.s. Commercial | Sale+OE | 19,388 | $16.87 | $327,085.25 | -30.5% | -2.7% | +42.6% | |
| Aug 12, 2024 | Daniell Richard | Exec. VP, European Commercial | Sell | 98,943 | $17.30 | $1,711,446.75 | -100% | +1.7% | -2.8% | |
| Aug 9, 2024 | Hughes Eric A | See "remarks" | Sell | 45,060 | $17.38 | $782,971.57 | -100% | +0.4% | -6.1% | |
| Aug 9, 2024 | Grant Angus | EVP, Business Development | Sale+OE | 4,065 | $17.28 | $70,243.20 | -31.5% | +0.4% | -6.1% | |
| Aug 1, 2024 | Hughes Eric A | See "remarks" | Sale+OE | 24,537 | $17.25 | $423,280.43 | -35.3% | +6.0% | -12.3% |